Navigation Links
Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
Date:4/23/2012

LA JOLLA, Calif., April 23, 2012 /PRNewswire/ -- Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that the Japan Patent Office has issued a Decision to Grant a Patent in the 'Sarnow' patent series for microRNA-122 (miR-122) therapy in the treatment of chronic hepatitis C virus (HCV) infection. The Sarnow patent estate, owned by Stanford University and exclusively licensed to Regulus, has already produced patents in Australia, Europe and the United States, and covers the use of a broad class of anti-miR inhibitors of miR-122 for the treatment of HCV.  

Regulus also announced today that the U.S. Patent and Trademark Office has allowed claims in a third Sarnow patent application, relating to the use of anti-miR-122 agents as monotherapy or in combination with other anti-viral therapies, to treat HCV-infected patients. 

"The recent allowance of miR-122 therapy claims further broadens Regulus' dominant and comprehensive intellectual property estate covering microRNA therapeutics," said Kleanthis G. Xanthopoulos, Ph.D., President and CEO of Regulus Therapeutics Inc.  "The HCV landscape continues to be a dynamic and ever-evolving space, with improvements upon direct-acting antiviral therapy on the horizon.  We believe anti-miR-122 is attractively positioned for use in combination with direct-acting antivirals to further reduce viral load and suppress viral resistance."

Regulus' Patent Estate for Anti-miR-122 Therapeutic Agents

Regulus controls a comprehensive and dominant patent estate related to microRNA therapeutics, including anti-miR-122 therapeutic agents. Specifically for miR-122, Regulus controls the following:

  • The 'Sarnow' patent estate claiming the use of an anti-miR-122 to treat HCV, as a single ther
    '/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Regulus Therapeutics and Collaborators Publish New Pre-Clinical Data on microRNA-33 Demonstrating Key Role in Cholesterol Homeostasis and Fatty Acid Metabolism
2. Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment
3. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
4. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
5. Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor
6. Rensselaer professor Jie Lian receives NSF CAREER Award
7. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
8. Watsons Generic BONIVA® 150mg Receives FDA Approval
9. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
10. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
11. Healing Spices Book Receives ABCs Duke Award for Consumer and Popular Books Category
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Ind. , July 10, 2014 /PRNewswire/ ... its use of capnography for respiratory monitoring ... group of healthcare leaders in embracing state-of-the-art ... how effectively patients are breathing and can ... occurs. By measuring the amount of carbon ...
(Date:7/10/2014)... --  Ceres, Inc . (Nasdaq: CERE ), ... results for the three months ended May 31, 2014 ... Ceres reported that the company and its customers have ... in Brazil, which concluded in June, despite dry and ... for part of the growing season. Yields of several ...
(Date:7/10/2014)... extremely challenging because there are many genetic variants that ... Now investigators reporting in the July 3rd issue of ... describe a strategy that may help reveal how such ... environmental exposures to affect the development of the nervous ... predispose individuals to schizophrenia. , The work takes ...
(Date:7/10/2014)... University of Illinois at Urbana-Champaign provides new insights ... spin and heat at the nanoscale, and addresses ... data storage and information processing. , "Electrons ... In a typical charge current, electrons, spin-angular-momentum is ... David Cahill, a professor of materials science and ...
Breaking Biology Technology:Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9New strategy could uncover genes at the root of psychiatric illnesses 2University of Illinois study advances limits for ultrafast nano-devices 2
... Cell Therapeutics (CTI),(Nasdaq and MTA: CTIC) announced today that ... on February 27, 2009 in lieu of the Special,Meeting ... February 6, 2009.,Shareholders of record at the close of ... the Board of Directors, will be entitled to vote ...
... NVAX ) a clinical-stage vaccine company, announced ... Officer, will be presenting at the Phacilitate Vaccine Forum ... Grand Hyatt in Washington D.C. Dr. Heaton is ... technologies and other novel vaccine manufacturing solutions providing in ...
... Geron to Study GRNOPC1 in Patients with Acute Spinal Cord ... GERN ) announced that the U.S. Food and Drug,Administration ... application for the clinical trial of GRNOPC1 in patients with,acute ... with,the world,s first study of a human embryonic stem (hESC) ...
Cached Biology Technology:Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009 2Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009 3MultiVu Video Feed: Geron Receives FDA Clearance to Begin World's First Human Clinical Trial of Embryonic Stem Cell-Based Therapy 2
(Date:7/10/2014)... the main organization of the International Science and Business ... group of researchers, led by professor Won Do Heo, ... optogenetics that can remotely control specific receptors by light. ... has succeeded with neuronal differentiation inducement. , The most ... only light to activate neuronal functions without the need ...
(Date:7/10/2014)... a microbial megacity, teeming with life too small to ... types of bacteria can be found. Now scientists ... their own daily cyclesnot unlike the residents of a ... and eat at the same times., What,s more, it,s ... solar energy to help them photosynthesize food from inorganic ...
(Date:7/10/2014)... University of the Negev scientists have discovered that scorpions ... up before the evening hunt. , As ectothermic ... regulate,their internal temperature. The researchers believe that this platform ... increase their body temperature before they leave their hiding ... the wild large-clawed scorpions ( Scorpio maurus palmatus ) ...
Breaking Biology News(10 mins):New optogenetic tool for controlling neuronal signalling by blue light 2New research finds ocean's most abundant organisms have clear daily cycles 2New research finds ocean's most abundant organisms have clear daily cycles 3Scorpions are master architects, according to new research from Ben-Gurion University 2
... is a professional, scientific society of approximately 11,000 ... research institutes worldwide. Founded in 1986, AAPS provides ... knowledge among scientists to serve the public and ... scientific programs, on-going education, information resources, opportunities for ...
... Following the drought of 2012, the prices of ... significantly. In an effort to reduce their costs, pork ... and phosphorus (P). Researchers at the University of Illinois ... minerals in byproducts from the rendering industry. Professor ...
... Park Ridge, Ill. (April 23, 2013) This ... the world are gathering to share research on a ... growing global burden of chronic disease, there is particular ... in overall health. Several studies presented at the conference ...
Cached Biology News:2013 AAPS National Biotechnology Conference returns to San Diego 2Calculating phosphorus and calcium concentrations in meat and bone meal for pig diets 2New research points to benefits of eggs, even for those at cardiovascular risk 2
... raised against a partial recombinant ... SLC22A3 (NP_068812, 90 a.a. ... protein with GST tag. ... NM_021977 Protein ...
...
... Deletion Cosmid Cloning Kit enables you to ... and unbiased primary cosmid library of genomic ... deletion sublibraries. High efficiency cosmid library construction ... kit protocols. First, genomic DNA is randomly ...
Mouse monoclonal antibody raised against a partial recombinant AATK. NCBI Entrez Gene ID = AATK...
Biology Products: